Advisory Committees
-
Presentation Slides for the May 7-8, 2012 Meeting of the Pediatric Advisory Committee
Persons with disabilities having problems accessing any of the PDF files below may call (301) 796-3634 for assistance.
-
Presentations
- Differin Lotion (adapalene): Pediatric Focused Safety Review (PDF - 156KB)
- Dulera Inhalation Aerosol (mometasone furoate and formotorol fumarate): Pediatric Focused Safety Review (PDF - 223KB)
- Gardasil Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant: Pre-licensure Review (PDF - 170KB)
- Gardasil Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant: Post-licensure Review (PDF - 272KB)
- Informational Update: Preliminary Data from a Pilot Study of Proton Pump Inhibitor Use in Infants <1 year in Intensive Care Units (PDF - 243KB)
- Menveo Meningoccoccal (Groups A,C,Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine: Pre-licensure Review (PDF - 75KB)
- Menveo Meningoccoccal (Groups A,C,Y, and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine: Post-licensure Review (PDF - 223KB)
- MultiHance Injection (gadobenate dimeglumine): Pediatric Focused Safety Review (PDF - 170KB)
- Nasonex (mometasone furoate monohydrate): Pediatric Focused Safety Review (PDF - 145KB)
Tamiflu- CDC: Epidemiology in Influenza in Children and Clinical Complications (PDF - 2.4MB)- Tamiflu- Surveillance of Adverse Events Associated with Oseltamivir in a Healthcare Claims Database (PDF - 353KB)
- Tamiflu - TamifluĀ® (Oseltamivir) Safety Assessment, Vaccine Safety Datalink Project, 2007-2010 (PDF - 802KB)
- Tamiflu (oseltamivir):- Pediatric Focused Safety Review (PDF - 280KB)
- Tamiflu - Tamiflu (oseltamivir phosphate): Background Information and Drug Utilization Patterns (PDF - 97KB)
- Taxotere, Omnaris Nasal Spray, Natazia and Protonix: Pediatric Focused Safety Review (PDF - 301KB)
- Post-marketing Monitoring of Vaccine Safety (PDF - 304KB)
- Viread (tenofovir disoproxil fumarate): Pediatric Focused Safety Review (PDF - 210KB)
-
-
-







